Mothers and CareGivers Investing in Children Study 2.0 (MAGIC 2)

April 24, 2025 updated by: Elizabeth Widen, University of Texas at Austin

Mothers and CareGivers Investing in Children: MAGIC 2.0

The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that has been successfully implemented with families as part of the MAGIC 1.0 program trial (IRB#: 2015040017).

  • The primary aim is to investigate each intervention's impact on infant BMIZ at 13 months.
  • The investigators will also assess the effect of MAGIC-FEED on caregiver nutrition knowledge and feeding practices, responsive feeding, infant diet, and child self-regulatory abilities and assess how these factors impact child self-regulation of eating and adiposity.
  • Finally, the investigators will determine if the interventions demonstrate the factors necessary to be a successful intervention as determined by the RE-AIM and PRISM frameworks.

Study Overview

Detailed Description

Obesity is a significant public health problem and risk begins early in life. In the US, over 19% of children ages 2-19 have obesity with 6% of these children classified with severe obesity. Obesity prevalence is lower among 2- to 5-year-old children (13.4%); however, by age 6, one in 5 children has obesity. Rapid weight gain over the first year of life is associated with overweight or obesity in toddlers and young children, which then tracks across the life course. It is critical to intervene on modifiable factors early in life to support healthy growth and prevent obesity. This trial is implemented across the first year in this population to support child diet quality, self-regulatory skills related to eating and growth to prevent obesity.

Interventions during the first year of life have been implemented to prevent child obesity. Most focus on breast and bottle feeding during the first 6 months or feeding across infancy. Few have demonstrated lasting effects beyond infancy on a relative body size measure that accounts for height such as BMIZ, and none have reported effects on long-term adiposity measured with a sensitive assessment tool or have successfully impacted long-term relative body size or adiposity. Further, prior RCTs have predominately been conducted via home visits. MAGIC 2.0 uses a virtual platform which will allows us to leverage the well-established effectiveness of home visiting to be accessible to caregivers with young children.

Study Type

Interventional

Enrollment (Estimated)

266

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Deborah Jacobvitz, PhD

Study Contact Backup

Study Locations

    • Texas
      • Austin, Texas, United States, 78723
      • Austin, Texas, United States, 78712
        • Not yet recruiting
        • Sarah M. & Charles E. Seay Building
        • Contact:
          • Deborah Jacobvitz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • A singleton infant 3-9 weeks of age, born ≥37 weeks gestation.
  • The mother and other caregiver must be at least 18 years of age.
  • The infant must live with the mother.
  • Lives within the Austin metropolitan area.
  • English or Spanish speaking.
  • The primary caregiver must identify as the mother.

Exclusion Criteria:

  • Infant diagnosed with major physical disabilities and/or medical condition that affects feeding and growth, and/or born <37 weeks gestation.
  • Infant experienced NICU stay >7 days.
  • Twins, triplets, or other multiples.
  • Mothers and/or other caregivers younger than 18 years old.
  • Mothers that do not consent to being video recorded with their baby.
  • Families that do not speak either English or Spanish will be excluded from this study. Families that only speak English or Spanish, or families that speak English or Spanish and another language, will be accepted.
  • Do not plan to remain in Austin area for the next two years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: MAGIC-SAFE
Parents will be provided with information about age-appropriate safety topics, including safe sleeping, car seats, baby-proofing, etc. The intervention is delivered via virtual visits, binder, website and newsletters.
Parents will be provided with information about age-appropriate safety topics, including safe sleeping, car seats, baby-proofing, etc. The intervention is delivered via virtual visits, binder, website and newsletters.
Experimental: MAGIC-FEED
Parents will be provided with responsive feeding coaching to help them recognize hunger and satiety cues and nutrition coaching that includes bottle-/breast-feeding and complementary feeding in alignment with the Dietary Guidelines. The intervention is delivered via virtual visits, binder, website and newsletters.
Parents will be provided with responsive feeding coaching to help them recognize hunger and satiety cues and nutrition coaching that includes bottle-/breast-feeding and complementary feeding in alignment with the Dietary Guidelines. The intervention is delivered via virtual visits, binder, website and newsletters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infant Body Mass Index Z-score (BMIZ) at 13 and 24 months
Time Frame: 13 & 24 months
Assessed via anthropometrics and WHO Child Growth Standards.
13 & 24 months
Infant dietary quality index
Time Frame: 0-13 months
Infant dietary quality index (IDQI) score with higher scores indicating higher dietary quality (Au et al. J Nutr 2023, 153(3): 741-748). Calculated with questionnaire data from an adapted Infant Feeding Practices III Food Frequency Questionnaire.
0-13 months
Infant self-regulation during feeding
Time Frame: 0-13 months
Infant self-regulation during feeding coded from video observation via the Nursing Child Assessment Feeding Scale.
0-13 months
Eating self-regulation
Time Frame: 24 months
Assessed via 'Eating in the Absence of Hunger' experiment using standard protocols (Asta et al. Pediatrics 2016;137(5):e20153786).
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver nutrition knowledge
Time Frame: 0-24 months
Caregiver nutrition knowledge assessed by the Infant Feeding Education Questionnaire.
0-24 months
Caregiver sensitivity
Time Frame: 0-24 months
Caregiver responsive feeding/sensitivity with higher scores indicating greater sensitivity. Assessed by Chatoor's Feeding Scale, Hazen Sensitivity Scale and Nursing Child Assessment Feeding Scale.
0-24 months
Solid food introduction timing
Time Frame: 0-8 months
Timing of solid food introduction (<6 mo, >=6 mo). Assessed by the adapted Infant Feeding Practices III Questionnaire.
0-8 months
Percentage body fat
Time Frame: 13 & 24 months
Percentage body fat assessed via DXA.
13 & 24 months
Proportion with BMIZ >=95%ile
Time Frame: 13 & 24 months
High BMI at 13 & 24 months
13 & 24 months
BMIZ change from 3 wk to 24 months
Time Frame: 0-24 months
BMIZ change from 3 wk to 24 months assessed via anthropometrics and WHO Child Growth Standard.
0-24 months
Child self-regulation
Time Frame: 24 months
Inhibitory control assessed via behavioral rating from the Barrier Box Tax with higher scores indicating greater regulation.
24 months
Caregiver infant feeding practices
Time Frame: 0-24 months
Assessed by the Feeding Practices and Structure Questionnaire.
0-24 months
Baby Eating Behavior
Time Frame: ~ 8 months
Infant eating behaviors assessed via the Baby Eating Behavior Questionnaire.
~ 8 months
Child Eating Behavior
Time Frame: 24 months
Child eating behaviors assessed via the Children's Eating Behavior Questionnaire.
24 months
Duration of exclusive breastfeeding
Time Frame: 0-24 months
Duration of exclusive breastfeeding assessed via the adapted Infant Feeding Practices III Questionnaire.
0-24 months
Sugary beverages before 12 months
Time Frame: 0-12 months
Introduction of sugary beverages prior to 12 months. Assessed via the adapted Infant Feeding Practices III questionnaire.
0-12 months
Child self-regulation
Time Frame: 13 months
Assessed by the Brief Infant Toddler Social Emotional Assessment (BITSEA) with higher scores indicating greater self-regulation.
13 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth Widen, PhD, RD, UT Austin
  • Principal Investigator: Deborah Jacobvitz, PhD, UT Austin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2025

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

October 23, 2024

First Submitted That Met QC Criteria

December 4, 2024

First Posted (Actual)

December 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • UT Austin IRB#STUDY00005620

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Growth

Clinical Trials on MAGIC-SAFE

Subscribe